How to buy Syneos Health (SYNH) stock

Syneos Health, Inc is a diagnostics & research business based in the US. Syneos Health shares (SYNH) are listed on the NASDAQ and all prices are listed in US Dollars. Syneos Health employs 24,310 staff and has a trailing 12-month revenue of around 0.00.

Syneos Health stock price (NASDAQ: SYNH)

Use our graph to track the performance of SYNH stocks over time.

Syneos Health shares at a glance

• Key figures

Information last updated 2021-07-22.

Latest market close	$84.00
52-week range	$50.27 - $92.25
50-day moving average	$87.01
200-day moving average	$80.98
Wall St. target price	$97.80
PE ratio	46.8617
Dividend yield	N/A (0%)
Earnings per share (TTM)	$1.88

Buy Syneos Health shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

*Signup bonus information updated weekly.

Is it a good time to buy Syneos Health stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of Syneos Health, Inc by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Syneos Health price performance over time

Historical closes compared with the close of $84 from 2021-06-08

1 week (2021-07-16)	N/A
1 month (2021-06-25)	-5.58%
3 months (2021-04-27)	-3.79%
6 months (2021-01-23)	N/A

1 year (2020-07-23)	N/A
2 years (2019-07-23)	N/A
3 years (2018-07-23)	N/A
5 years (2016-07-23)	N/A

Is Syneos Health under- or over-valued?

Valuing Syneos Health stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Syneos Health's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Syneos Health's P/E ratio

Syneos Health's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 47x. In other words, Syneos Health shares trade at around 47x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

Syneos Health's PEG ratio

Syneos Health's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.3731. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Syneos Health's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Syneos Health's EBITDA

Syneos Health's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $587.5 million.

The EBITDA is a measure of a Syneos Health's overall financial performance and is widely used to measure a its profitability.

Syneos Health financials

Revenue TTM	$4.5 billion
Operating margin TTM	8.15%
Gross profit TTM	$1 billion
Return on assets TTM	2.92%
Return on equity TTM	6.37%
Profit margin	4.44%
Book value	$31.06
Market capitalisation	$9.1 billion

TTM: trailing 12 months

Shorting Syneos Health shares

There are currently 4.0 million Syneos Health shares held short by investors – that's known as Syneos Health's "short interest". This figure is 10.4% down from 4.5 million last month.

There are a few different ways that this level of interest in shorting Syneos Health shares can be evaluated.

Syneos Health's "short interest ratio" (SIR)

Syneos Health's "short interest ratio" (SIR) is the quantity of Syneos Health shares currently shorted divided by the average quantity of Syneos Health shares traded daily (recently around 1.7 million). Syneos Health's SIR currently stands at 2.42. In other words for every 100,000 Syneos Health shares traded daily on the market, roughly 2420 shares are currently held short.

However Syneos Health's short interest can also be evaluated against the total number of Syneos Health shares, or, against the total number of tradable Syneos Health shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Syneos Health's short interest could be expressed as 0.04% of the outstanding shares (for every 100,000 Syneos Health shares in existence, roughly 40 shares are currently held short) or 0.0389% of the tradable shares (for every 100,000 tradable Syneos Health shares, roughly 39 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Syneos Health.

Find out more about how you can short Syneos Health stock.

Syneos Health share dividends

We're not expecting Syneos Health to pay a dividend over the next 12 months.

Syneos Health share price volatility

Over the last 12 months, Syneos Health's shares have ranged in value from as little as $50.265 up to $92.25. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Syneos Health's is 1.8292. This would suggest that Syneos Health's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Syneos Health overview

Syneos Health, Inc. provides biopharmaceutical outsourcing solutions company in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers various services spanning Phases I to IV of clinical development, including full service global studies, as well as individual service offerings, such as clinical monitoring, investigator recruitment, patient recruitment, data management, and study startup to assist customers with their drug development process. The Commercial Solutions segment provides commercialization services comprising deployment solutions; communications solutions, such as public relations, advertising, and medical communications; and consulting services. Its customers include small, mid-sized, and large companies in the pharmaceutical, biotechnology, and medical device industries. Syneos Health, Inc.

Frequently asked questions

What percentage of Syneos Health is owned by insiders or institutions?
Currently 0.239% of Syneos Health shares are held by insiders and 89.698% by institutions. How many people work for Syneos Health?
Latest data suggests 24,310 work at Syneos Health. When does the fiscal year end for Syneos Health?
Syneos Health's fiscal year ends in December. Where is Syneos Health based?
Syneos Health's address is: 1030 Sync Street, Morrisville, NC, United States, 27560-5468 What is Syneos Health's ISIN number?
Syneos Health's international securities identification number is: US87166B1026 What is Syneos Health's CUSIP number?
Syneos Health's Committee on Uniform Securities Identification Procedures number is: 45329R109